MicroRNA 1471 (MIR1471)

MicroRNA 1471 (MIR1471) is a small, non-coding RNA molecule classified as a microRNA[2][3]. MicroRNAs (miRNAs) are typically 21–23 nucleotides in length and regulate gene expression post-transcriptionally by binding complementary sequences in messenger RNAs, leading to mRNA degradation or translational inhibition[3]. While many miRNAs are implicated in essential processes such as cell differentiation, proliferation, apoptosis, and disease states like cancer, not all are functionally annotated or considered therapeutic targets. As of now, there is no evidence for MIR1471’s involvement in any biological pathway, disease process, or therapeutic targeting, nor has it been identified as a biomarker or drug target in peer-reviewed literature or curated genomic databases[2][3]. Its presence in databases reflects annotation rather than validation through functional studies or clinical relevance. MIR1471 is a microRNA gene noted in the human genome, but it is not considered a validated or characterized molecular target, nor does it have recognized roles in disease, molecular functions, or pharmacological interactions. There is no evidence for its candidacy as a therapeutic target based on current scientific literature[2][3].

Other names

hsa-mir-1471MIRN1471MIR1471